Skip to content

Clinical trials

Phase 2 Idiopathic Pulmonary Fibrosis trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 2 Country / region: Belgium Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20133
20161
20181
20191
20202
20221
20234
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting5
Terminated5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim3
Hoffmann-La Roche3
Pliant Therapeutics, Inc.2
Biogen1
Bristol-Myers Squibb1
CSL Behring1
Centocor, Inc.1
Endeavor Biomedicines, Inc.1
Erasme University Hospital1
Galecto Biotech AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis20
Pulmonary Fibrosis5
Fibrosis2
Idiopathic Interstitial Pneumonias1
Lung Diseases, Interstitial1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.